United States:
Why Cannabis Patent Enforcement Is In The Weeds
11 July 2019
Oblon, McClelland, Maier & Neustadt, L.L.P
To print this article, all you need is to be registered or login on Mondaq.com.
The article "Why Cannabis Patent Enforcement is in the
Weeds," written by Daniel Pereira and contributed to by summer
associate Alec Royka, is featured by Managing Intellectual
Property.
Resources
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
